A MULTIFACETED APPROACH TO PAIN RELIEF IN PATIENTS WITH SOFT TISSUE INJURIES

Download full text PDF
Issue: 
11
Year: 
2016

None

The major symptom of soft tissue injury is pain that may occur for many reasons. The use of conventional analgesics can mask pain, which can lead to deterioration of the patient’s condition, prevent recovery, and potentially contribute to the occurrence of new injuries. The use of Traumeel S is an alternative approach to treating inflammation and easing pain.

Keywords: 
traumatology
soft tissue injuries
pain
nonsteroidal anti-inflammatory drugs
Traumeel S



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Speed C., Hazleman B., Dalton S. Fast Facts: Soft Tissue Disorders, 2nd ed. / Oxford: Health Press Limited, 2006.
  2. Selvanetti A. Overuse tendon injuries: basic science and classification // Operat. Tech. Sports Med. – 1997; 5: 110–7.
  3. Bahr R. No injuries, but plenty of pain? On the methodology for recording overuse symptoms in sports // Br. J. Sports Med. – 2009; 43: 966–72.
  4. van Tulder M., Malmivaara A., Koes B. Repetitive strain injury // Lancet. – 2007; 369: 1815–22.
  5. Laker S., Sullivan W., Strum S. Overuse injury // Medscape. – 2008. Available at: http://emedicine.medscape.com/article/313121-Overview
  6. Paoloni J., Milne C., Orchard J. et al. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use // Br. J. Sports Med. – 2009; 43: 863–5.
  7. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials // Lancet. – 2013; 382: 769–79.
  8. Trelle S., Reichenbach S., Wandel S. et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network analysis // BMJ. – 2011; 342: 7086.
  9. Castellsague J., Riera-Guardia N., Calingaert B. et al. on behalf of the investigators of the Safety of Non-Steroidal Anti-inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications. A systematic review and metaanalysis of observational studies (the SOS Project) // Drug Saf. – 2012; 35: 1127–45.
  10. Barkin R., Beckerman M., Blum S. et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? // Drugs Aging. – 2010; 27: 775–89.
  11. Evans J., McMahon A., McGilchrist M. et al. Topical nonsteroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case–control study // BMJ. – 1995; 311: 22–6
  12. Antman E., Bennett J., Daugherty A. et al. Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association // Circulation. – 2007; 115: 1634–42.
  13. Evans J., McGregor E., McMahon A. et al. Nonsteroidal anti-inflammatory drugs and hospitalization for acute renal failure // QJM. – 1995; 88: 551–7.
  14. Laine L., Goldkind L., Curtis S. et al. How common is diclofenacassociated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial // Am. J. Gastroenterol. – 2009; 104: 356–62.
  15. Barkin R. Topical nonsteroidal anti-inflammatory drugs: the importance of drug, delivery, and therapeutic outcome // Am. J. Ther. – 2012: published online 22 February 2012, doi: 10.1097/MJT.0b013e3182459abd
  16. FitzGerald G., Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2 // N. Engl. J. Med. – 2001; 345: 433–42.
  17. Brewer A., McCarberg B., Argoff C. Update on the use of topical NSAIDs for the treatment of soft tissue and musculoskeletal pain: a review of recent data and current treatment options // Phys. Sportsmed. – 2010; 38: 62–70.
  18. Kienzler J., Gold M., Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers // J. Clin. Pharmacol. – 2010; 50: 50–61.
  19. Heyneman C., Lawless-Liday C., Wall G. Oral versus topical NSAIDs in rheumatic diseases: a comparison // Drugs. – 2000; 60: 555–74.
  20. Argoff C. Topical analgesics in the management of acute and chronic pain // Mayo Clin. Proc. – 2013; 88: 195–205.
  21. Singh P., Roberts M. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application // J. Pharmacol. Exp. Ther. – 1994; 268: 144–51.
  22. Radermacher J., Jentsch D., Scholl M. et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease // Br. J. Clin. Pharmacol. – 1991; 31: 537–41.
  23. Brune K. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability // Curr. Med. Res. Opin. – 2007; 23: 2985–95.
  24. Wolfe M., Lichenstein D., Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs // N. Engl. J. Med. – 1999; 340: 1888–99.
  25. McGettigan P., Henry D. Cardiovascular risk with nonsteroidal anti-inflammatory drugs: systematic review of populationbased controlled observational studies // PLoS Med. – 2011; 8: e1001098.
  26. Barbe M., Barr A. Inflammation and the pathophysiology of work-related musculoskeletal disorders // Brain Behav. Immun. – 2006; 20: 423–9.
  27. Barr A., Barbe M., Clark B. Systemic inflammatory mediators contribute to widespread effects in work-related musculoskeletal disorders // Exerc. Sport Sci. Rev. – 2004; 32: 135–42.
  28. Muller-Wohlfahrt H.-W., Haensel L., Mithoefer K. et al. Terminology and classification of muscle injuries in sport: the Munich consensus statement // Br. J. Sports Med. – 2013; 47: 342–50.
  29. Ziltener J.-L., Leal S., Fournier P.-E. Non-steroidal anti-inflammatory drugs for athletes: an update // Ann. Phys. Rehab. Med. – 2010; 53: 278–88.
  30. Orchard J., Best T., Muller-Wohlfahrt H.-W. et al. The early management of muscle strains in the elite athlete: best practice in a world with a limited evidence basis // Br. J. Sports Med. – 2008; 42: 158–9.
  31. Orchard J., Best T. The management of muscle strain injuries: an early return versus the risk of recurrence // Clin. J. Sports Med. – 2002; 12: 3–5.
  32. Kannus P., Parkkari J., Jarvinen T. et al. Basic science and clinical studies coincide: active treatment approach is needed after a sports injury // Scand. J. Med. Sci. Sports. – 2003; 13: 150–4.
  33. Cesnulevicius K. The bioregulatory approach to work-related musculoskeletal disorders: using the multicomponent ultra low-dose medication Traumeel to target the multiple pathophysiological processes of the disease // Altern. Ther. Health Med. – 2011; 17 (Suppl. 2): S8–17.
  34. Lussignoli S., Bertani S., Metelmann H. et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats // Complement. Ther. Med. – 1999; 7: 225–30.
  35. Zell J., Connert W., Mau J. et al. Behandlung von akuten Sprunggelenksdistorsionen: doppelblindstudie zum wirksamkeitsnachweis eines homoopathischen Salbenpraparats // Fortschr. Med. – 1988; 106: 96–100.
  36. Bohmer D., Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study // Biol. Ther. – 1992; 10: 290–300.
  37. Thiel W., Borho B. Posttraumatische Kniegelenksergusse und intra-artikulare Traumeel Injektion // Orthopadische Praxis. – 1991; 11: 721–5.
  38. Orizola A., Vargas F. The efficacy of Traumeel S versus diclofenac and placebo ointment in tendinous pain in elite athletes: a randomized controlled trial // Med. Sci. Sports Med. Exerc. – 2007; 39 (5 Suppl.): S79, abstract 858.
  39. Gonzalez de Vega C., Speed C., Wolfarth B. et al. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial // Int. J. Clin. Pract. – 2013; 67: 979–89.
  40. Wolfarth B., Gonzalez de Vega C. Make an impact on your daily practice: the potential role for a natural multi-target medication // Curr. Med. Res. Opin. – 2013; 29 (Suppl. 2): 15–9.
  41. Schneider C. Traumeel – an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries // Int. J. Gen. Med. – 2011; 4: 225–34.